Effects of compounds acting on GABA(B) receptors in the pentylenetetrazole kindling model of epilepsy in mice

Neuropharmacology

Volumn 39, Issue 11, 2000, Pages 2147-2161

  De Sarro, Giovambattista ^a   Palma, Ernesto ^b   Costa, Nicola ^b   Rosario Marra, ^b   Gratteri, Santo ^a   De Sarro, Angela ^c   Rotiroti, Domenicantonio ^b  

^a Dipto Med Sperim Clin Univ C   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^c UNIVERSITY OF MESSINA   (Italy)

Author keywords

3 1 (S) (3,4 dichloro phenyl ethyl amino 2 (S) hydroxy propyl benzyl phosphinic acid (CGP 55845A); 3 amino propyl diethoxy methyl phosphinic acid (CGP 35348); Epileptic discharges; GABA(B) receptor; Kindling; Pentylenetetrazole; R baclofen; Seizure

Indexed keywords

3 AMINOPROPYL(DIETHOXYMETHYL)PHOSPHINIC ACID; 4 AMINOBUTYRIC ACID B RECEPTOR BLOCKING AGENT; 4 AMINOBUTYRIC ACID B RECEPTOR STIMULATING AGENT; BACLOFEN; BENZYL[3 [[1 (3,4 DICHLOROPHENYL)ETHYL]AMINO] 2 HYDROXYPROPYL]PHOSPHINIC ACID; GABAERGIC RECEPTOR AFFECTING AGENT; PENTETRAZOLE; PROTEIN C FOS; PROTEIN C JUN; R BACLOFEN; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; DOSE RESPONSE; ELECTROCORTICOGRAPHY; EPILEPSY; EPILEPTIC DISCHARGE; KINDLING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CEREBRAL CORTEX; CONVULSANTS; DISEASE MODELS, ANIMAL; EPILEPSY; GABA ANTAGONISTS; KINDLING, NEUROLOGIC; MALE; MICE; PENTYLENETETRAZOLE; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; RECEPTORS, GABA-B;

EID: 0033838084     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(00)00050-2     Document Type: Article

References (75)

1. Ault B., Nadler J.V. Anticonvulsant-like actions of baclofen in the rat hippocampal slice. British Journal of Pharmacology. 78:1983;701-708.
2. B receptor antagonist, CGP 56999A. European Journal of Pharmacology. 333:1997;135-142.
3. Banerjee P.K., Snead O.C. Thalamic NMDA receptors in the γ-hydroxybutyrate model of absence seizures: a cerebral microinjection study in rats. Neuropharmacology. 34:1995;43-53.
4. Benedito M.A.C., Leite J.R. Baclofen as an anticonvulsant in experimental models of convulsions. Experimental Neurology. 72:1981;346-351.
5. B antagonists: Potential new drugs. Pharmacological Communication. 2:1992;70-74.
6. B receptor antagonists: From synthesis to therapeutic applications. Trends in Pharmacological Science. 14:1993;391-394.
7. B agonists and antagonists in rat dorso-lateral septal neurones in vitro. British Journal of Pharmacology. 118:1996;961-967.
8. B receptors. Trends in Pharmacological Science. 14:1993;259-264.
9. B receptors that mediate inhibition of GABA and glutamate release in human neocortex. British Journal of Pharmacology. 120:1997;60-64.
10. B receptors and their significance in mammalian Pharmacology. Trends in Pharmacological Science. 10:1989;401-407.
11. B receptor pharmacology. Annual Review in Pharmacology and Toxicology. 33:1993;109-147.
12. B receptors. Role and therapeutic implications in CNS disorders. CNS Drugs. 7:1997;167-175.
13. Clark M., Post R.M., Weiss S.R.B., Chain C.J., Nakajima T. Regional expression of Fos mRNA in rat brain during the evolution of amygdala kindled seizures. Molecular Brain Research. 11:1991;55-64.
14. Coulter D.A., Zhang Y. Thalamocortical rhythm generation in vitro: physiological mechanisms, pharmacological control, and relatevance to generalized absence epilepsy. Maiorasse A., Genton P., Hirsch E., Marescaux C., Broglin D., Bernasconi R. Idiopathic Generalized Epilepsies: Clinical, Experimental and Genetic Aspects. 1994;123-131 John Libbey, London.
15. B receptor in excitation and inhibition of thalamocortical cells. Trends in Neuroscience. 14:1991;16-21.
16. B receptors on epileptic electrocortical discharges induced by pilocarpine or NMDA. Pharmacological Communications. 8:1996;111-116.
17. Dragunow M., Faull R. The use of Fos as a metabolic marker in neuronal pathway tracing. Journal of Neuroscience Methods. 29:1989;261-265.
18. Durmuller N., Craggs M., Meldrum B.S. The effect of the non-NMDA receptor antagonists GYKI 52466 and NBQX and the competitive NMDA receptor antagonists D-CPPene on the development of amygdala kindling and on amygdala-kindled seizures. Epilepsy Research. 17:1994;167-174.
19. B receptors in the central nervous system. Nature. 332:1988;156-158.
20. Ebert U., Löscher W. Strong induction of Fos in the piriform cortex during focal seizures evoked from different limbic brain sites. Brain Research. 671:1995;338-344.
21. B modulators. Enna S.J., Bowery N.G. The GABA receptors. 1997;271-296 Humana Press, Totowa.
22. B antagonists. Pharmacol. Commun., 2, 52-56.
23. B receptor antagonists. Pharmacological Communication. 8:1996;127-133.
24. Gass P., Herdegen T., Bravo R., Kiessling M. Induction of immediate early gene encoded proteins in the rat hippocampus after bicuculline-induced seizures: Differential expression of KROX-24, FOS and JUN proteins. Neuroscience. 48:1992;315-324.
25. B receptor antagonism on the development of pentylenetetrazole-induced kindling in mice. Brain Research. 809:1998;182-188.
26. B sites in rat brain. Nature. 290:1981;149-152.
27. B receptor activation in absence seizures of lethargic (1 h/1 h) mice. Science. 257:1992;398-401.
28. B receptors regulate absence seizures in the lethargic (1 h/1 h) mouse model. Journal of Neuroscience. 15:1995;7367-7376.
29. B receptor antagonist, in the lethargic mouse, gamma-hydroxybutyrate, and pentylenetetrazole models. Journal of Pharmacological Experimental Theory. 274:1995;1399-1403.
30. Karlen R., Murphy V., Colder L.D., Turkanis S.A. Pentylenetetrazole kindling in mice. Neuropharmacology. 28:1989;775-780.
31. B receptors in Mammalian Function. 1990;349-365 John Wiley and Sons, Chichester.
32. B receptor blocker CGP 35348. Neuroscience. 47:1992;63-68.
33. Kiessling M., Gass P. Immediate early gene expression in experimental epilepsy. British Journal of Pathology. 3:1993;381-393.
34. King M.A., Thinschmidt J.S., Walker D.W. Gammahydroxybutyrate (GHB) receptor ligand effects on evoked synaptic field potentials in CA1 of the rat hippocampal slice. Journal of Neural Transmission. 104:1997;1177-1193.
35. B receptors in rats with spontaneous generalized no convulsive epilepsy. Journal of Neural Transmission. 35:1992;189-196.
36. Kraus, J.E., Yeh, G.-C., Bonhaus, Nadler, J.V., McNamara, J.O., 1994. Kindling induces the long-lasting expression of a novel population of NMDA receptors in hippocampal region CA3. Journal of Neuroscience, 14, 4196-4205.
37. Labiner D.M., Butler L.S., Cao Z., Hosford D.A., Shin C., McNamara J.O. Induction of Fos mRNA by kindled seizures: Complex relationship with neuronal burst firing. Journal of Neuroscience. 13:1993;744-751.
38. Lanaud P., Maggio R., Gale K., Grayson D.R. Temporal and spatial patterns of expression of Fos, zif/268, Jun and jun-B mRNAs in rat brain following seizures evoked focally from the deep prepiriform cortex. Experimental Neurology. 119:1993;20-31.
39. B receptors facilitates muscarinic agonist-induced epileptiform activity in immature rat piriform cortex in vitro. Naunyn-Schmiedeberg's Archives of Pharmacology. 358:1998;168-174.
40. Liu Z., Vergnes M., Depaulis A., Marescaux C. Evidence for a critical role of GABAergic transmission within the thalamus in the genesis and control of absence seizures in the rat. Brain Research. 545:1991;1-7.
41. B neurotransmission in the control of absence seizures in the rat. Neuroscience. 48:1992;87-93.
42. B receptors in the lethargic (l h/l h) mouse model of absence epilepsy. Brain Research. 608:1993;101-106.
43. Löscher W. Which animal models should be used in the search for new antiepileptic drugs. Epilepsia. 34:1993;188.
44. Löscher W., Honack D. Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice comparisons with diazepam and interactions with flumazenil. British Journal of Pharmacology. 113:1994;1349-1357.
45. Luhmann H.J., Mittmann T., van Luijtelaar G., Heinemann U. Impairment of intracortical GABAergic inhibition in a rat model of absence epilepsy. Epilepsy Research. 22:1995;43-51.
46. B receptor are involved in the occurrence of absence seizures in rats. Pharmacological Communication. 2:1992;57-62.
47. B receptor antagonists: potential new antiabsence drugs. Journal of Neural Transmission. 35:1992;179-188.
48. B antagonists on generalised non-convulsive and convulsive seizures. Pharmacological Communication. 8:1996;187-201.
49. B receptor binding sites in genetic absence epilepsy rats from Straosburg (GAERS) and in non-epileptic control rats. Maiarosse A., Genton P., Hirsch E., Marescaux C., Brogrin D., Bernasconi R. Idiopathic Generalized Epilepsies: Clinical Experimental and Genetic Aspects. 1994;177-185 John Libbey, London.
50. B receptors in GAERS compared to non-epileptic control rats using agonist and antagonist radioligands. Pharmacological Communication. 8:1996;203-207.
51. McNamara J.O. Development of new pharmacological agents for epilepsy: Lesson from the kindling model. Epilepsia. 31:1989;S13-S18.
52. McNamara J.O. Cellular and molecular basis of epilepsy. Journal of Neuroscience. 14:1994;3413-3425.
53. A receptors. Enna S.J., Bowery N.G. The GABA receptors. 1997;203-209 Humana Press, Totowa.
54. B receptor activation in area CA3 of rat hippocampus. Brain Research. 600:1993;235-242.
55. Mott D.D., Bragdon A.C., Lewis D.V., Wilson W.A. Baclofen has a proepiletic effect in the rat dentate gyrus. Journal of Pharmacological Experimental Theory. 249:1989;721-725.
56. Mutani R., Cantello R., Gianelli M., Betticcu D. Rational basis for the development of new antiepileptic drugs. Epilepsy Research. 19:1991;23-28.
57. B) receptor subtype. Brain Research. 604:1993;325-330.
58. Piredda S., Yonekawa W., Whittingham T.S., Kupferberg H.J. Enhanced bursting activity in the CA3 region of the mouse hippocampal slice without long-term potentiation in the dentate gyrus after systemic pentylenetetrazole kindling. Experimental Neurology. 94:1986;659-669.
59. B type. European Journal of Pharmacology. 144:1987;45-52.
60. Potier B., Dutar P. Presynaptic inhibitory effect of baclofen on hippocampal inhibitory synaptic transmission involves a pertussis toxin-sensitive G-protein. European Journal of Pharmacology. 231:1993;427-433.
61. Rush J.M., Gibberd F.B. Baclofen induced epilepsy. Journal of the Royal Society of Medicine. 83:1990;115-116.
62. B receptors in hippocampal epileptogenesis. Pharmacological Communication. 2:1992;50.
63. B receptors in the generation of epileptiform activity in disinhibited hippocampal slice cultures. Neuroscience. 61:1994;823-832.
64. Schmidt J. Changes in seizure susceptibility in rats following chronic administration of pentylenetetrazole. Biomedical Biochemistry Acta. 46:1987;267-270.
65. Slotnick, B.M., Leonard, C.M., 1975. Albino mouse brain. US Dept. of Health Education and Welfare Publication No. 74100.
66. Smiler S., Hirsch E., Danober L., Motte J., Vergnes M., Marescaux C. Fos expression after single and kindled audiogenic seizures in Wistar rats. Neuroscience Letters. 175:1994;58-62.
67. B antagonist CGP-35348 blocks spike-wave bursts in the cholesterol synthesis rat absence epilepsy model. Brain Research. 729:1996;147-150.
68. B and gamma-hydroxybutyric acid receptor antagonists. Pharmacological Biochemistry and Behaviour. 53:1996;73-79.
69. B and γ-hydroxybutyric acid (GHB) receptor antagonists. Pharmacogical Biochemistry and Behaviour, in press.
70. B and γ-hydroxybutyric acid-mediated mechanisms in generalized absence seizures. Neuropharmacology. 35:1996;359-367.
71. Vergnes M., Marescaux C., Depaulis A., Micheletti G., Warter J.M. Spontaneous spike and wave discharges in the thalamus and cortex in a rat model of genetic petit mal-like seizures. Experimental Neurology. 96:1987;127-136.
72. Vergnes M., Marescaux C., Depaulis A., Micheletti G., Warter J.M. The spontaneous spike and wave discharges in Wistar rats: a model of genetic generalized nonconvulsive epilepsy. Avoli M., Gloor P., Kostopoulos P., Naquet R. Generalized Epilepsy, Neurobiological Approaches. 1990;238-253 Birkhauser, Boston.
73. Vergnes M., Marescaux C., Depaulis A. Mapping of spontaneous spike and wave discharges in Wistar rats with genetic generalized non convulsive epilepsy. Brain Research. 593:1990;87-91.
74. B receptor antagonists on absences and convulsive seizures. European Journal of Pharmacology. 332:1997;245-255.
75. B receptor antagonists with similar potency: no evidence for pharmacologically different presynaptic receptors. British Journal of Pharmacology. 113:1994;1515-1521.